variable | TB treatment n (%) | Lung cancer n (%) | P value |
---|---|---|---|
Demographic | |||
Age, years | 62.1 (25.0–80.0) | 65.4 (45.0–83.0) | 0.151 |
Male, n (%) | 29 (93.5) | 43 (84.3) | 0.220 |
BMI (kg/m2) | 20.8 | 21.9 | 0.024 |
Smoker, n (%) | 20 (64.5) | 28 (54.9) | 0.398 |
Laboratory | |||
Hypoalbuminemia, n (%) | 15 (48.4) | 12 (23.5) | 0.020 |
Anemia, n (%) | 12 (38.7) | 17 (33.3) | 0.627 |
Liver dysfunction, n (%) | 5 (16.1) | 8 (15.7) | 0.958 |
Renal dysfunction, n (%) | 7 (22.6) | 12 (23.5) | 0.923 |
ESR elevation, n (%) | 12 (48.0) | 13 (32.5) | 0.218 |
Cancer | |||
Tumor burden, n (%) | 28 (90.3) | 42 (82.4) | 0.328 |
Type | |||
Non-small cell, n (%) | 25 (80.6) | 37 (72.5) | 0.635 |
Adenocarcinoma | 10 (32.3) | 17 (33.3) | |
Squamous cell | 15 (48.3) | 19 (37.3) | |
Large cell | 0 | 1 (1.9) | |
Small cell, n (%) | 6 (19.4) | 14 (27.5) | |
Stage | |||
Not evaluable | 6 (19.4) | 5 (9.8) | 0.269 |
I, n (%) | 0 (0) | 2 (3.9) | |
II, n (%) | 2 (6.5) | 3 (5.9) | |
III, n (%) | 4 (12.9) | 15 (29.4) | |
IV, n (%) | 19 (61.3) | 26 (50.9) | |
KPS | 84 ± 8 | 86 ± 9 | 0.333 |